Trellus Management Company’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$564K Buy
155,012
+54,976
+55% +$301K 0.78% 29
2023
Q2
$596K Buy
100,036
+54,581
+120% +$432K 0.74% 34
2023
Q1
$548K Buy
45,455
+12,122
+36% +$162K 0.64% 30
2022
Q4
$290K Buy
33,333
+19,912
+148% +$439K 0.37% 46
2022
Q3
$389K Sell
13,421
-5,064
-27% -$232K 0.47% 35
2022
Q2
$769K Buy
18,485
+17,076
+1,212% +$1.16M 0.94% 20
2022
Q1
$143K Buy
+1,409
New +$157K 0.08% 54

Other funds holding WGS

Trellus Management Company's WGS Position: Q3 2023 in Review

Trellus Management Company increased its GeneDx Holdings (WGS) stake by 55% in Q3 2023, buying an estimated $301K and bringing the position to 155,012 shares worth $564K. The position accounts for 0.78% of the portfolio, ranked #29.

Trellus Management Company first reported a position in WGS in Q1 2022 and has held it in 7 quarters since. The position peaked at $769K in Q2 2022. 53 funds tracked by Wall St. Rank hold WGS as of Q3 2023.

  • Trellus Management Company held 155,012 shares of GeneDx Holdings worth $564K as of Q3 2023.
  • Trellus Management Company bought 54,976 GeneDx Holdings shares in Q3 2023, an estimated $301K.
  • GeneDx Holdings made up 0.78% of Trellus Management Company's portfolio in Q3 2023, its #29 holding.
  • Trellus Management Company first reported a position in GeneDx Holdings in Q1 2022 and has held it in 7 quarters since.
  • Trellus Management Company's GeneDx Holdings position peaked at $769K in Q2 2022.
  • 53 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2023.

Based on Trellus Management Company's 13F filing for Q3 2023, filed 24 Oct 2023.